Immix Biopharma, Inc. IMMX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Immix Biopharma, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s cash ratio?
- Immix Biopharma, Inc. (IMMX) reported cash ratio of 7.5× in Q1 2026.
- How has Immix Biopharma, Inc.'s cash ratio changed year-over-year?
- Immix Biopharma, Inc.'s cash ratio increased by 339.6% year-over-year, from 1.7× to 7.5×.
- What is the long-term trend for Immix Biopharma, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s cash ratio has grown at a 162.7% compound annual growth rate (CAGR), from 0.1× to 9.3×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.